Impact of the US Food and Drug Administration’s safety-related announcements on the use of bisphosphonates after hip fracture

The U.S. FDA issued several announcements related to potential risk of bisphosphonates including osteonecrosis of the jaw (2005), atrial fibrillation (2007) and atypical femur fracture (2010). We aimed to evaluate the impact of three FDA drug safety announcements on the use of bisphosphonates in pat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Bone Miner Res
Autores principales: Kim, Seoyoung C., Kim, Dae Hyun, Mogun, Helen, Eddings, Wesley, Polinski, Jennifer M., Franklin, Jessica M., Solomon, Daniel H
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5040596/
https://ncbi.nlm.nih.gov/pubmed/26969902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.2832
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares